NCT04703894 is a NA clinical trial of AYMES 'CARDIFF' in Malnutrition, sponsored by Aymes International Limited.

Who is sponsoring NCT04703894?

NCT04703894 is sponsored by Aymes International Limited.

What drugs are being tested in NCT04703894?

Interventions in NCT04703894: AYMES 'CARDIFF'.

What condition does NCT04703894 study?

NCT04703894 studies Malnutrition.

Is NCT04703894 still recruiting?

NCT04703894 is currently completed. Last updated 11 January 2021.

Last reviewed 2021-01-11 · How we verify

NCT04703894

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tolerance and Acceptability Evaluation AYMES Cardiff

Completed NA Last updated 11 January 2021

What this trial tests

NA trial testing AYMES 'CARDIFF' in Malnutrition in 17 participants. Completed in 13 January 2020.

Timeline

6 November 2019

Primary endpoint
13 January 2020

13 January 2020

Quick facts

Lead sponsor	Aymes International Limited
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	17
Start date	6 November 2019
Primary completion	13 January 2020
Estimated completion	13 January 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

AYMES 'CARDIFF'

Conditions studied

Malnutrition — all drugs for Malnutrition →

Sponsor

Aymes International Limited — full company profile →

Who can join

18 and older, any sex, with Malnutrition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate tolerance and acceptability of 'CARDIFF' in patients requiring supplementary oral nutritional support compared with currently available alternatives.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Malnutrition

Currently open trials in the same condition.

NCT07162701 — Body Composition Assessment and Monitoring in Inflammatory Bowel Disease · recruiting
NCT05324475 — Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition. · NA · recruiting
NCT06825377 — Comparing High-protein Vs. Standard Protein Nutritional Support in Critically Ill Patients At Risk for Refeeding Syndrom · NA · recruiting
NCT06687291 — Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer · recruiting
NCT06837194 — Washed Microbiota Transplantation Combined With Enteral Nutrition for Gastroptosis · recruiting

Other Aymes International Limited trials

Trials by the same sponsor.

NCT07452523 — Tolerance, Palatability and Acceptability Evaluation of an Oral Nutrition Supplement · NA · active not recruiting
NCT04703881 — Tolerance and Acceptability Evaluation AYMES ActaGain · NA · completed
NCT04700293 — Tolerance and Acceptability Evaluation of AYMES AMSTERDAM · NA · completed
NCT03844373 — Tolerance and Acceptability Evaluation of STOCKHOLM · NA · completed
NCT03836274 — Tolerance and Acceptability Evaluation of MONACO · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04703894 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aymes International Limited
Last refreshed: 11 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04703894.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing